During its November 21, 2017 meeting, the Board approved $57 million to fund 14 new comparative clinical effectiveness research (CER) studies. The funds will support studies of a range of conditions and problems that impose high burdens on patients, caregivers and the healthcare system. The total includes $32 million to fund three large-scale pragmatic clinical studies, and $25 million for 11 additional studies on topics such as anxiety disorders and substance abuse. Read more about the projects.
All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period.